Association of Cyclooxygenase 2 Single-Nucleotide Polymorphisms and Hepatocellular Carcinoma in Taiwan

Chinese Journal of Physiology

Volumn 55, Issue 1, 2012, Pages 1-7

  Chang, Wen Shin ^a   Yang, Mei Due ^a   Tsai, Chia Wen ^a,b   Cheng, Li Hao ^b   Jeng, Long Bin ^a   Lo, Woei Chung ^c   Lin, Chih Hsueh ^c   Huang, Chih Yang ^b,d   Bau, Da Tian ^a,b  

^a Terry Fox Cancer Research Laboratory   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

COX 2; Hepatocellular carcinoma; Polymorphism

Indexed keywords

ADENINE; CYCLOOXYGENASE 2; CYTOSINE; GUANINE; THYMINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DRINKING BEHAVIOR; ENVIRONMENTAL FACTOR; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TUMOR DIFFERENTIATION;

EID: 84455163120     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2012.AMM056     Document Type: Article

References (33)

1. Avila, M.A., Berasain, C., Sangro, B. and Prieto, J. New therapies for hepatocellular carcinoma. Oncogene 25: 3866-3884, 2006.
2. Bae, S.H., Jung, E.S., Park, Y.M., Kim, B.S., Kim, B.K., Kim, D.G. and Ryu, W.S. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin. Cancer Res. 7: 1410-1418, 2001.
3. Casado, M., Callejas, N.A., Rodrigo, J., Zhao, X., Dey, S.K., Bosca, L. and Martin-Sanz, P. Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. Faseb. J. 15: 2016-2018, 2001.
4. Casado, M., Molla, B., Roy, R., Fernandez-Martinez, A., Cucarella, C., Mayoral, R., Bosca, L. and Martin-Sanz, P. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology 45: 631-638, 2007.
5. Chang, C.H., Chang, C.L., Tsai, C.W., Wu, H.C., Chiu, C.F., Wang, R.F., Liu, C.S., Lin, C.C. and Bau, D.T. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res. 29: 1777-1782, 2009.
6. Chang, C.H., Chiu, C.F., Liang, S.Y., Wu, H.C., Chang, C.L., Tsai, C.W., Wang, H.C., Lee, H.Z. and Bau, D.T. Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res. 29: 1275-1279, 2009.
7. Chen, C.J., Yu, M.W. and Liaw, Y.F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 12: S294-S308, 1997.
8. Chiu, C.F., Tsai, M.H., Tseng, H.C., Wang, C.L., Wang, C.H., Wu, C.N., Lin, C.C. and Bau, D.T. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol. 44: 898-902, 2008.
9. Chiu, C.F., Wang, C.H., Wang, C.L., Lin, C.C., Hsu, N.Y., Weng, J.R. and Bau, D.T. A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann. Surg. Oncol. 15: 514-518, 2008.
10. Chiu, C.F., Wang, H.C., Wang, C.H., Wang, C.L., Lin, C.C., Shen, C.Y., Chiang, S.Y. and Bau, D.T. A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. Anticancer Res. 28: 267-270, 2008.
11. Cok, S.J. and Morrison, A.R. The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J. Biol. Chem. 276: 23179-23185, 2001.
12. Davies, G., Salter, J., Hills, M., Martin, L.A., Sacks, N. and Dowsett, M. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin. Cancer Res. 9: 2651-2656, 2003.
13. Department of Health, Taiwan. Cancer registration system annual report. Taiwan, Department of Health, 2008.
14. DeWitt, D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta. 1083: 121-134, 1991.
15. Gorgoni, B., Caivano, M., Arizmendi, C. and Poli, V. The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem. 276: 40769-40777, 2001.
16. Hsu, C.F., Tseng, H.C., Chiu, C.F., Liang, S.Y., Tsai, C.W., Tsai, M.H. and Bau, D.T. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncol. 45: 789-793, 2009.
17. Hsu, N.Y., Wang, H.C., Wang, C.H., Chiu, C.F., Tseng, H.C., Liang, S.Y., Tsai, C.W., Lin, C.C. and Bau, D.T. Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan. Anticancer Res. 29: 725-730, 2009.
18. Jiang, M.C., Liao, C.F. and Lee, P.H. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem. Biophys. Res. Commun. 282: 671-677, 2001.
19. Koga, H., Sakisaka, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., Nakashima, Y., Nakashima, O., Kojiro, M., Kurohiji, T. and Sata, M. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29:688-696, 1999.
20. Levitt, R.J. and Pollak, M. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells. Cancer Res. 62: 7372-7376, 2002.
21. Lim, W., Kwon, S.H., Cho, H., Kim, S., Lee, S., Ryu, W.S. and Cho, H. HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression. J. Mol. Med. 88: 359-369, 2010.
22. Martin-Sanz, P., Mayoral, R., Casado, M. and Bosca, L. COX-2 in liver, from regeneration to hepatocarcinogenesis: what we have learned from animal models? World J. Gastroenterol. 16: 1430-1435, 2010.
23. Mayoral, R., Fernandez-Martinez, A., Bosca, L. and Martin-Sanz, P. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis 26: 753-761, 2005.
24. Mayoral, R., Molla, B., Flores, J.M., Bosca, L., Casado, M. and Martin-Sanz, P. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury. Biochem. J. 416: 337-346, 2008.
25. Mizutani, Y., Kamoi, K., Ukimura, O., Kawauchi, A. and Miki, T. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. J. Urol. 168: 2650-2654, 2002.
26. Papafili, A., Hill, M.R., Brull, D.J., McAnulty, R.J., Marshall, R.P., Humphries, S.E. and Laurent, G.J. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler. Thromb. Vasc. Biol. 22: 1631-1636, 2002.
27. Sanchez-Alcazar, J.A., Bradbury, D.A., Pang, L. and Knox, A.J. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Lung Cancer 40: 33-44, 2003.
28. Shiota, G., Okubo, M., Noumi, T., Noguchi, N., Oyama, K., Takano, Y., Yashima, K., Kishimoto, Y. and Kawasaki, H. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 46: 407-412, 1999.
29. Sung, Y.K., Hwang, S.Y., Kim, J.O., Bae, H.I., Kim, J.C. and Kim, M.K. The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis. Mol. Cells 17: 35-38, 2004.
30. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. and DuBois, R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998.
31. Vecchini, A., Ceccarelli, V., Susta, F., Caligiana, P., Orvietani, P., Binaglia, L., Nocentini, G., Riccardi, C., Calviello, G., Palozza, P., Maggiano, N. and Di Nardo, P. Dietary alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells. J. Lipid Res. 45: 308-316, 2004.
32. Williams, C.S., Mann, M. and DuBois, R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999.
33. Yang, M.D., Hsu, Y.M., Kuo, Y.S., Chen, H.S., Chang, C.L., Wu, C.N., Chang, C.H., Liao, Y.M., Wang, H.C., Wang, M.F. and Bau, D.T. Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. Anticancer Res. 29: 2239-2242, 2009.